# Vivian Fonseca

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vivian-fonseca/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,732 |
| Field | Diabetes Treatment and Management |
| h-index | 104 |
| i10-index | 356 |
| Last Known Institution | Tulane University |
| OpenAlex ID | https://openalex.org/A5034671525 |
| ORCID iD | 0000-0002-3381-7151 |
| Works | 736 |

## Researcher papers

- [The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults](https://scholariq.org/papers/the-metabolic-syndrome-and-chronic-kidney-disease-in-u-s-adults/)
- [American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease](https://scholariq.org/papers/american-association-of-clinical-endocrinologists-and-american-college-of-2/)
- [Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus](https://scholariq.org/papers/primary-prevention-of-cardiovascular-diseases-in-people-with-diabetes-mellitus-2/)
- [Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY](https://scholariq.org/papers/consensus-statement-by-the-american-association-of-clinical-endocrinologists-and/)
- [Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure](https://scholariq.org/papers/thiazolidinedione-use-fluid-retention-and-congestive-heart-failure/)
- [Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension](https://scholariq.org/papers/metabolic-effects-of-carvedilol-vs-metoprolol-in-patients-with-type-2-diabetes/)
- [American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules](https://scholariq.org/papers/american-association-of-clinical-endocrinologists-and-associazione-medici/)
- [Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus](https://scholariq.org/papers/primary-prevention-of-cardiovascular-diseases-in-people-with-diabetes-mellitus/)
- [Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure](https://scholariq.org/papers/thiazolidinedione-use-fluid-retention-and-congestive-heart-failure-2/)
- [Defining and Characterizing the Progression of Type 2 Diabetes](https://scholariq.org/papers/defining-and-characterizing-the-progression-of-type-2-diabetes/)
- [Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease](https://scholariq.org/papers/safety-of-liraglutide-in-type-2-diabetes-and-chronic-kidney-disease/)
- [Predicting incident heart failure among patients with type 2 diabetes mellitus: The <scp>DM‐CURE</scp> risk score](https://scholariq.org/papers/predicting-incident-heart-failure-among-patients-with-type-2-diabetes-mellitus/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

## Researcher university

- [Tulane University](https://scholariq.org/institutions/tulane-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.